All pharmaceutical interventions Articles
-
41ClinicalTalking to Parents About Myopia Gets More Pediatric Patients in My Office Chair
April 15, 2024 By Jamie Brosof, OD The first step in our office is starting the conversation about myopia management with my...
-
79ClinicalLow-dose Atropine and OrthoK: What Does the Evidence Say?
April 1, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
533ClinicalLow-Dose Atropine: An Effective and Safe Option for Managing Juvenile-onset Myopia
sponsored content March 1, 2024 The evidence supporting the use of topical low-dose atropine in treating juvenile-onset myopia is so strong that...
-
477Latest Myopia NewsEyenovia Regains Rights to MicroPine Atropine Spray in U.S. and Canada
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
-
944ClinicalEarly Intervention of Low-Dose Atropine is Key for Juvenile-Onset Myopes
January 15, 2024 Review of Myopia Management interviewed Robert Clark, MD, to get the latest insights on treating myopes with low-dose atropine....
-
1.2KClinicalImplementing Myopia Management Allows Me to Provide Preventative Care
January 15, 2024 By Tobin Ansel, OD, MS, FAAO Implementing myopia management into practice is a process, and it starts with something...
-
1.2KClinicalEffect of Low-Concentration Atropine Eye Drops on Myopia Incidence
January 1, 2024 By Huy Tran, MD, PhD, and Thi D. Duong, BOptom While myopia control treatment has been successfully adopted worldwide,1...
-
1.3KClinicalAffirming the Importance of Short-Term Trials Complemented with Long-Term Follow-Up
December 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Clinical trial results of topical atropine eye drops for childhood myopia...
-
1.0KClinicalObstacles with Compounded Low-Dose Atropine
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
-
1.3KIn The PipelineiVeena’s IVMED-85 Receives NEI-SBIR Grant
October 27, 2023 SALT LAKE CITY — iVeena Delivery Systems‘ Dr. Sarah Molokhia, vice president of research and development, was awarded a...
-
1.5KClinicalPediatric Ophthalmologists Dive Deep on Low-Dose Atropine for Myopia Management
sponsored content August 15, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management ‘Pediatric ophthalmologists are the tip of the spear....
-
1.5KClinicalSafe and Effective Low-Dose Atropine Can Be Stable and Comfortable Too
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...
-
2.0KClinicalThe Ins and Outs of Vyluma’s CHAMP Study
sponsored content June 1, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management At this year’s Global Specialty Lens Symposium, Mark...
-
2.0KClinicalA Pediatric Ophthalmologist’s Take on Myopia Management
April 17, 2023 By Carolyn Lederman, MD I’ve found that it’s been helpful when talking to parents about myopia management to tell...
-
1.7KClinicalCase Study: One Treatment Adds a Second in Combination
March 15, 2023 By Matthew J. Martin, OD, FIAOMC Subjective A 12-year-old female Asian patient “WG” was referred to our office by...
-
1.9KClinicalShould Atropine Be Prescribed for All Children Wearing OrthoK?
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
-
1.7KClinicalCase Study: Patients’ Lifestyles Yield Best Treatment Outcomes
March 1, 2023 By Vittorio Mena OD, MS Subjective Two children, accompanied by their parents, presented at my clinic for comprehensive eye...
-
1.3KClinicalFrom Dabbler to Myopia Practitioner of the Year
sponsored content November 15, 2022 By Chris Browning, OD If you want to do myopia management and do it well, you have...
-
791ClinicalVyluma’s Navneet Puri and Raul Trillo Discuss CHAMP Study Results
sponsored content November 1, 2022 Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives...
-
2.5KClinicalVyluma CHAMP Pivotal Phase 3 Clinical Trial Q&A
sponsored content October 27, 2022 Vyluma aims to preserve the vision of a global population by providing meaningful and effective pharmaceutical ophthalmic...
-
4.7KBinocular VisionListening to Patients’ Needs Led Me to Myopia Management
April 15, 2022 By David Anderson, OD If I could say anything to a doctor who might ask me what to do...
-
1.2KClinicalRecent Updates on Combination Treatments for Myopia Control
March 1, 2022 By Dr. Pavan K. Verkicharla and Mr. Swapnil Thakur It is important to note that there will be non-responders...
-
2.7KClinicalCommitment to Myopia Management Creates Lasting Changes in Your Practice
December 15, 2021 By Ashley Tucker, OD, FAAO, FSLS, ABO Diplomate I always say that I am prescribing myopia management and not...
-
4.2KClinicalEmbracing the Latest Technology Can Build A Stronger Myopia Management Practice
November 15, 2021 By Nathan Bonilla-Warford, OD, FAAO, FCOVD, FIAOMC More recently, we’ve shifted our attention to TikTok. It is the only...
-
3.0KClinicalDangers of High Myopia
sponsored content November 15, 2021 By Craig Brawley, OD, FAAO; Kevin Chan, OD, MS, FAAO; Millicent Knight, OD, FAAO, FAARM, FNAP; Pamela...
-
4.6KBinocular VisionMy U.K. Experience with Myopia Management
November 1, 2021 By Nick Dash, BScHons (Bio), BScHons (Optom), MCOptom, Dip. SVA Myopia is more than diopters. It is more than...
-
2.9KClinical
Advancing Myopia Therapy with IVMED-85
October 15, 2021 By Bala Ambati, MD, PhD, President and Founder, iVeena & Sarah Molokhia, RPh, PhD, VP for Research & Development,...